Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Register

Sign In

EUR/USD

1.1790

-0.0046

-0.39%

GBP/USD

1.3432

0.0021

0.16%

USD/JPY

112.26

-0.4700

-0.42%

USD/CHF

0.9877

0.0023

0.23%

EUR/GBP

0.8778

-0.0048

-0.55%

USD/CAD

1.2754

-0.0063

-0.49%

NZD/USD

0.6989

-0.0030

-0.43%

EUR/JPY

132.35

-1.0795

-0.81%

EUR/CHF

1.1645

-0.0019

-0.16%

Akers Biosciences Inc.

NASDAQ: AKERHealthcare / Medical Instruments & Supplies / USA
0.37-0.01-2.63%Vol 145 7601Y Perf -73.71%
Dec 14th, 2017 15:26
BID0.37 ASK0.38
Open0.38 Previous Close0.38
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)4 
Earnings Rating
Price Range Ratio 52wk %
0.39 
Earnings Date

Today's Price Range

0.360.39

 

52wk Range

0.362.90

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-49.33%
3 Months
-62.00%
6 Months
-69.60%
1 Year
-73.71%
3 Years
-88.20%
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
AKER0.37-0.0100-2.63
AAPL172.330.06000.03
GOOG1 048.407.79000.75
MSFT84.68-0.6700-0.79
XOM83.08-0.0400-0.05
WFC59.38-0.0200-0.03
JNJ141.73-1.1600-0.81
FB178.530.23000.13
GE17.66-0.1000-0.56
JPM104.80-0.7100-0.67
...

TickerPriceChg.%52 Week High
FOXA35.097.1535.04
FOX34.336.1534.34
MAT16.375.0031.60
DIS111.293.42116.10
TIF99.163.18100.80
DAL55.182.8955.75
STZ223.842.41227.20
WMB29.732.3132.69
CBS58.231.8570.10
EQIX459.581.84495.35
EXPE120.541.68161.00
MCK157.771.65169.29
COP52.531.6454.22
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.90
Current Ratio 2.50
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -697.70
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin61.90
EBIT Margin-134.80
EBITDA Margin-127.10
Pre-tax Profit Margin-170.40
Profit Margin-91.32
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.76
PS Ratios 0.02
Price to Cash Flow 44.60
Price to Free Cash Flow -1.50
Cash Flow Per Share -0.43
Price to Tangible Book2.52
Book Value per Share0.40
Enterprise Value (in ths.)6 842
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-59.10
ROE last 12 Months -101.92
Return on Assets (5Y Avg) -69.80
ROA last 12 Months -75.86
Return on Capital (5Y Avg) -55.57
ROC last 12 Months -102.09
Return on invested Capital Q -26.06
Return on invested Capital Y-66.57
Assets Turnover0.20
Receivables Turnover1.50
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)3 194
Revenue per Share 25.58
Revenue Growth 3 Years 1.25
Revenue Growth 5 Years 13.58
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2016--0.19-
Q01 2016--0.28-
Q04 2015--0.69-
Q03 2015--0.36-
Q02 2015--0.41-
Q01 2015--0.26-
Q04 2014--0.19-
Q03 2014--0.23-
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date13th Nov 2017
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume145 760
Shares Outstanding (in ths.)9 920
Trades Count115
Dollar Volume462 102
Avg. Volume183 973
Avg. Weekly Volume674 671
Avg. Monthly Volume327 483
Avg. Quarterly Volume337 493

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

80%20%

Bearish Bullish

77%23%

Bearish Bullish

64%36%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Strong Buy
1.00

There are no comments yet.

News

x